Skip to main content
ABOS logo

ABOS · Acumen Pharmaceuticals, Inc.

$2.13 -0.04 (-1.84%) At close · Jul 24
Market Cap
$156.73M
Shares
72.23M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
61/100
Short interest 3.9% of shares — P65 Days to cover 7.5 — P82 Price vs VWAP -9.7% — P29 Short-volume trend +14.1% — P85 Short interest change +0.9% — P53 Worst FTD 0.00% of shares — P26

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-08-14 Scheduled
FINRA publishes Aug 25
2026-07-31 Scheduled
FINRA publishes Aug 11
2026-07-15 2,814,458 2,788,975 +25,483 7.51
2026-06-30 2,788,975 1,886,963 +902,012 2.60
2026-06-15 1,886,963 1,892,556 -5,593 5.87
2026-05-29 1,892,556 1,747,125 +145,431 5.49
2026-05-15 1,747,125 1,675,956 +71,169 6.39
2026-04-30 1,675,956 1,545,029 +130,927 5.17
2026-04-15 1,545,029 1,055,415 +489,614 3.08
2026-03-31 1,055,415 1,032,017 +23,398 1.00
2026-03-13 1,032,017 960,875 +71,142 3.10
2026-02-27 960,875 947,292 +13,583 3.60
2026-02-13 947,292 900,167 +47,125 2.35
2026-01-30 900,167 599,667 +300,500 1.00
2026-01-15 599,667 553,811 +45,856 2.56
2025-12-31 553,811 568,193 -14,382 3.00
2025-12-15 568,193 575,361 -7,168 4.01
2025-11-28 575,361 1,318,100 -742,739 3.50
2025-11-14 1,318,100 1,374,712 -56,612 6.96
2025-10-31 1,374,712 1,332,676 +42,036 4.06
2025-10-15 1,332,676 1,311,722 +20,954 2.63
2025-09-30 1,311,722 1,357,015 -45,293 2.65
2025-09-15 1,357,015 1,405,707 -48,692 10.41
2025-08-29 1,405,707 1,380,944 +24,763 5.83
2025-08-15 1,380,944 1,401,436 -20,492 5.55
2025-07-31 1,401,436 1,505,384 -103,948 3.29
Showing 1–24 of 24 settlements
Key facts CIK 1576885 CUSIP 00509G209 13F (30d) 10 filings 10 filers Visit website Investor relations